| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 18.71▼ | 18.73▼ | 18.84▼ | 18.99▼ | 18.51▼ |
| MA10 | 18.73▼ | 18.96▼ | 19.00▼ | 18.45▼ | 20.62▼ |
| MA20 | 18.93▼ | 19.06▼ | 19.07▼ | 18.75▼ | 22.38▼ |
| MA50 | 19.07▼ | 19.04▼ | 18.65▼ | 20.92▼ | 28.17▼ |
| MA100 | 18.99▼ | 18.54▼ | 18.66▼ | 22.53▼ | 28.11▼ |
| MA200 | 18.50▲ | 19.05▼ | 20.08▼ | 27.04▼ | 24.16▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.034▼ | -0.076▼ | -0.094▼ | 0.202▲ | -0.285▼ |
| RSI | 32.234▼ | 36.804▼ | 38.610▼ | 38.798▼ | 29.533▼ |
| STOCH | 35.814 | 20.427 | 28.847 | 62.419 | 10.463▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -61.024 | -87.717▼ |
| CCI | -152.817▼ | -152.607▼ | -192.623▼ | 21.790 | -95.532 |
|
Thursday, September 24, 2026 12:00 AM
Mesoblast’s Ryoncil ® (remestemcel-L-rknd) for the treatment of steroid-refractory acute graft versus host disease (SR-aGvHD) in pediatric patients 2 months and older is the first FDA-approved ...
|
|
Monday, August 24, 2026 04:06 AM
NEW YORK, Aug. 24, 2026 (GLOBE NEWSWIRE)-- Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, will host a webcast to discuss ...
|
|
Thursday, May 14, 2026 07:42 AM
Mesoblast Ltd (ASX:MSB; Nasdaq:MESO) stock rose 2.01% to $14.73 on May 13, 2026, fueled by Phase 3 trial progress for rexlemestrocel-L and FDA clearance for Ryoncil in Duchenne muscular dystrophy.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 23/10/26 | 19.06 | 19.3773 | 18.24 | 18.24 | 82,362 |
| 22/10/26 | 19.05 | 19.44 | 18.92 | 19.28 | 20,749 |
| 21/10/26 | 19.24 | 19.35 | 18.94 | 19.07 | 22,680 |
| 20/10/26 | 18.91 | 19.48 | 18.7957 | 19.16 | 39,913 |
| 19/10/26 | 18.08 | 19.79 | 18.08 | 19.19 | 81,990 |
| 16/10/26 | 17.78 | 18.7425 | 17.4619 | 17.88 | 92,443 |
| 15/10/26 | 18.26 | 18.38 | 17.84 | 18.04 | 47,000 |
| 14/10/26 | 17.63 | 18.16 | 17.31 | 18.06 | 33,800 |
| 13/10/26 | 17.67 | 17.99 | 17.57 | 17.74 | 28,747 |
| 12/10/26 | 18.43 | 18.70 | 17.26 | 17.83 | 57,200 |
|
|
||||
|
|
||||
|
|